| Registered Office:
103 F-1 Leela Apartment Shilpa,HSG Society Shanidham Narendra,Nagpur-440015,
Maharashtra |
| Tel. No: +91 712 278 6666 |
| Fax No: NA |
| Email: info@goldlinepharma.in |
| Website: www.goldlinepharma.in |
| Initial public offer of upto 30,00,000 equity shares of face value of Rs. 10/- each ("equity shares") of the company at an issue price of Rs. [*] per equity share (including a share premium of Rs. [*] per equity share) for cash, aggregating up to Rs. [*] crores ("public issue") out of which [*] equity shares of face value of Rs. 10/- each, at an issue price of Rs. [*] per equity share for cash, aggregating Rs. [*] crores will be reserved for subscription by the market maker to the issue (the "market maker reservation portion"). The public issue less market maker reservation portion i.e. issue of [*] equity shares of face value of Rs. 10/- each, at an issue price of Rs. [*] per equity share for cash, aggregating up to Rs. [*] crores is hereinafter referred to as the "net issue". The public issue and net issue will constitute [*]% and [*]% respectively of the post- issue paid-up equity share capital of the company.
The price band and the minimum bid lot will be decided by the company. |
